These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27612480)

  • 1. Signatures of prostate-derived Ets factor (PDEF) in cancer.
    Mahajan N
    Tumour Biol; 2016 Nov; 37(11):14335-14340. PubMed ID: 27612480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDEF downregulates stathmin expression in prostate cancer.
    Sabherwal Y; Mahajan N; Helseth DL; Gassmann M; Shi H; Zhang M
    Int J Oncol; 2012 Jun; 40(6):1889-99. PubMed ID: 22378487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDEF in prostate cancer.
    Sood AK; Kim H; Geradts J
    Prostate; 2012 May; 72(6):592-6. PubMed ID: 21796651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.
    Steffan JJ; Koul HK
    Cancer Lett; 2011 Nov; 310(1):109-17. PubMed ID: 21764212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
    Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
    Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-Derived Ets Factor (PDEF) Inhibits Metastasis by Inducing Epithelial/Luminal Phenotype in Prostate Cancer Cells.
    Wang F; Koul S; Shanmugam PST; Dong Q; Koul HK
    Mol Cancer Res; 2018 Sep; 16(9):1430-1440. PubMed ID: 29848555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-derived Ets factor, an oncogenic driver in breast cancer.
    Sood AK; Geradts J; Young J
    Tumour Biol; 2017 May; 39(5):1010428317691688. PubMed ID: 28468594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor metastasis suppressor functions of Ets transcription factor through integrin β3-mediated signaling pathway.
    Pal M
    J Cell Physiol; 2019 Nov; 234(11):20266-20274. PubMed ID: 30982973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex.
    Cho JY; Lee M; Ahn JM; Park ES; Cho JH; Lee SJ; Kim BG; Heo SH; Park HJ; Zerbini LF; Hwang D; Libermann TA
    J Proteome Res; 2009 Mar; 8(3):1327-37. PubMed ID: 19203193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells.
    Tsui KH; Lin YH; Chung LC; Chuang ST; Feng TH; Chiang KC; Chang PL; Yeh CJ; Juang HH
    Cancer Lett; 2016 May; 375(1):142-151. PubMed ID: 26965996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic modifications of prostate-derived Ets transcription factor in breast cancer cells.
    Sabherwal Y; Mahajan N; Zhang M
    Oncol Rep; 2013 Oct; 30(4):1985-8. PubMed ID: 23921628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells.
    Gu X; Zerbini LF; Otu HH; Bhasin M; Yang Q; Joseph MG; Grall F; Onatunde T; Correa RG; Libermann TA
    Cancer Res; 2007 May; 67(9):4219-26. PubMed ID: 17483333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.
    Cheng XH; Black M; Ustiyan V; Le T; Fulford L; Sridharan A; Medvedovic M; Kalinichenko VV; Whitsett JA; Kalin TV
    PLoS Genet; 2014 Sep; 10(9):e1004656. PubMed ID: 25254494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression.
    Turner DP; Findlay VJ; Moussa O; Semenchenko VI; Watson PM; LaRue AC; Desouki MM; Fraig M; Watson DK
    Prostate; 2011 Dec; 71(16):1723-35. PubMed ID: 21446014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXB13 regulates the prostate-derived Ets factor: implications for prostate cancer cell invasion.
    Kim IJ; Kang TW; Jeong T; Kim YR; Jung C
    Int J Oncol; 2014 Aug; 45(2):869-76. PubMed ID: 24898171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEF.
    Johnson TR; Koul S; Kumar B; Khandrika L; Venezia S; Maroni PD; Meacham RB; Koul HK
    Mol Cancer; 2010 Jun; 9():148. PubMed ID: 20550708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer.
    Findlay VJ; Turner DP; Moussa O; Watson DK
    Cancer Res; 2008 Oct; 68(20):8499-506. PubMed ID: 18922924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.
    Sood AK; Saxena R; Groth J; Desouki MM; Cheewakriangkrai C; Rodabaugh KJ; Kasyapa CS; Geradts J
    Hum Pathol; 2007 Nov; 38(11):1628-38. PubMed ID: 17521701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDEF is a negative regulator of colon cancer cell growth and migration.
    Moussa O; Turner DP; Feldman RJ; Sementchenko VI; McCarragher BD; Desouki MM; Fraig M; Watson DK
    J Cell Biochem; 2009 Dec; 108(6):1389-98. PubMed ID: 19830706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression.
    Schaefer JS; Sabherwal Y; Shi HY; Sriraman V; Richards J; Minella A; Turner DP; Watson DK; Zhang M
    J Biol Chem; 2010 Apr; 285(15):11258-69. PubMed ID: 20139077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.